Sucralose Rewired Gut Bacteria and Serotonin Responses in Stress-Exposed Mice

If you reach for a zero-calorie sweetener while managing a gut condition, a new mouse study published in Nutrients adds a layer of complexity worth understanding. Researchers found that sucralose, one of the world's most widely consumed artificial sweeteners, did not act neutrally in animals under chronic psychological stress. Instead, it shifted gut microbial communities, reduced key metabolites, and altered how the colon's serotonin system responded to stimulation. This is early, investigational science conducted in mice, not humans, but its implications for anyone tracking the gut-brain connection are real enough to pay attention to.

Key takeaways:

• Sucralose altered gut microbial composition and reduced acetate and tryptophan levels in stress-exposed mice, but not in stress-free animals given the same sweetener.
• Higher-dose sucralose (0.1%) was associated with shorter colon length and a blunted behavioral response to a gut irritant, alongside changes in serotonin-related gene expression.
• The effects were stress-dependent: sucralose alone, without prior stress, did not produce the same serotonergic or behavioral changes.
• Both dose levels used exceeded the human acceptable daily intake, so direct translation to human consumption is limited.

Sucralose shifted gut microbiota composition in stress-exposed mice

Aoki, Jacobs, and Okamoto subjected male C57BL/6N mice to chronic restraint stress (CRS) for one hour per day across an 11-day period, then gave them either plain water, 0.03% sucralose, or 0.1% sucralose in their drinking water for the following 12 days. Using 16S rRNA gene sequencing (a method that identifies bacterial communities by their genetic fingerprints), the team found that microbial community composition differed significantly across groups, with the overall variation explained at R2 = 0.269 (p = 0.001). In plain terms: which bacteria were present, and in what proportions, shifted meaningfully depending on whether an animal received sucralose and at what dose.

One species stood out sharply. Bacteroides acidifaciens, a commensal bacterium (one that normally lives in the gut without causing harm) associated with short-chain fatty acid production, was significantly reduced in the high-dose sucralose group. This reduction in B. acidifaciens tracked alongside lower fecal acetate concentrations, the primary short-chain fatty acid (a compound produced when gut bacteria ferment fiber) that feeds colon cells and regulates immune tone. Acetate was already lower in stressed mice given plain water compared to non-stressed animals; high-dose sucralose pushed it lower still.

Earlier human research on sucralose's varying effects on gut microbiota has yielded inconsistent results, with some trials finding no shifts and others reporting increases in potentially harmful genera. This mouse study adds a possible reason for that inconsistency: stress context may determine whether sucralose affects the microbiome at all, since the behavioral and serotonergic changes were not seen in non-stressed animals given sucralose alone.

Why this matters for people managing IBS or stress-related gut symptoms

Disorders of gut-brain interaction (DGBIs), the umbrella category that includes irritable bowel syndrome (IBS), are defined by chronic GI symptoms arising from complex signaling between the gut and the brain. Psychological stress is a well-established trigger: it changes intestinal permeability, disrupts microbial balance, and alters how the gut generates and responds to serotonin, a neurotransmitter that governs motility, sensation, and pain signaling in the intestine.

For the roughly 10 to 15 percent of adults who live with IBS, many of whom also report heightened stress and regularly consume low-calorie sweeteners as part of a dietary management strategy, these interactions are not academic. Broader evidence that synthetic sweeteners reduce gut microbial diversity has already begun reshaping clinical conversations about sweetener safety in gut-compromised populations. This study adds a specific mechanistic thread: the combination of chronic stress and sucralose may compound the disruption that either factor creates alone.

The stress-dependent nature of the findings is important to name explicitly. Sucralose alone, in non-stressed mice, did not produce the same microbial, metabolic, or serotonergic changes. That conditional quality is actually informative: it suggests the gut's baseline resilience may buffer sweetener effects, and that compromised or chronically stressed guts may be more vulnerable.

What the study measured and how

Beyond the microbiome sequencing, the researchers measured fecal short-chain fatty acids and cecal tryptophan-related metabolites via liquid chromatography-tandem mass spectrometry (LC-MS/MS, a highly sensitive chemical detection method). Cecal tryptophan (an amino acid precursor to serotonin) was significantly reduced in the high-dose sucralose group. That finding connects to another: the gene for Tph1 (tryptophan hydroxylase 1, the enzyme that converts tryptophan into serotonin in gut cells) was suppressed by stress and partially restored by sucralose treatment, while the gene for Slc6a4 (the serotonin transporter, which removes serotonin from the space between cells) was elevated in high-dose sucralose animals.

In a separate animal cohort, the team used AITC (allyl isothiocyanate, the active compound in mustard oil) to irritate the colon and trigger a measurable behavioral response, immobility, which reflects discomfort rather than direct pain intensity. Stressed mice given high-dose sucralose showed significantly less immobility in response to AITC than stressed vehicle-treated mice, and their colonic epithelial concentrations of 5-HT (serotonin) and 5-HIAA (its breakdown product) were elevated post-stimulation. The researchers interpret this as a shift in how the colon's serotonin system responds to a visceral challenge, not necessarily a reduction in sensitivity, but a change in the dynamics of serotonin release and clearance.

What this could mean for your gut health, and what remains unproven

If you have IBS, IBD, or another stress-related gut condition, this study is worth knowing about, not as a reason to panic, but as a signal to watch. The serotonin system in the gut regulates how we perceive and respond to intestinal discomfort; anything that alters it under stress conditions is relevant to symptom variability. Growing evidence links sucralose's effects on the gut-immune axis to preclinical signals involving barrier function and mucosal inflammation, though none of this has been established in controlled human trials.

What this study does not prove: it does not show that sucralose causes IBS, worsens symptoms, or is harmful at amounts humans typically consume. The study doses (39.4 mg/kg/day and 136.8 mg/kg/day) exceeded the human acceptable daily intake, which the authors explicitly flag as a limitation on direct extrapolation. It also does not establish that any specific bacterium or metabolite caused the observed serotonergic changes; those causal links remain to be tested.

If you are managing a gut condition and regularly consume sucralose, it is reasonable to mention this class of research to a gastroenterologist, not because action is indicated now, but because the stress-sweetener-microbiome interaction is an emerging area where guidance may evolve.

Open questions this study leaves unanswered

Several important gaps remain. The study used only male mice, so sex-based differences in the stress-sucralose interaction are unknown. The microbiome data reflects which bacteria are present, not what those bacteria are doing, since 16S rRNA sequencing does not capture functional pathways. Causal direction between B. acidifaciens loss, acetate reduction, and serotonergic shifts was not established. And because the behavioral and microbiome analyses were conducted in separate animal cohorts, there is no individual-level data linking one animal's microbial profile to its serotonin response.

The small sample size (six animals per group) also limits statistical confidence, particularly for null findings like the unchanged intestinal permeability. Replication in larger studies, in female animals, and ultimately in humans under stress conditions, is needed before any clinical guidance can follow.

Common Questions

Does sucralose affect the gut microbiome in humans? Human studies have produced inconsistent results: some find no significant change in bacterial composition after sucralose consumption, while others report shifts toward potentially harmful genera. This mouse study suggests stress context may partly explain that variability, but human trials testing sucralose under stress conditions have not yet been done.

Is sucralose safe for people with IBS? Current regulatory bodies consider sucralose safe at established intake levels, and this study does not overturn that. However, the stress-dependent gut changes observed in mice are a reason for people with IBS to discuss sweetener use with a gastroenterologist, particularly if symptoms vary with stress.

Why does serotonin matter for gut symptoms? Roughly 95 percent of the body's serotonin is produced in the gut, where it regulates muscle contractions, fluid secretion, and pain signaling. Disruptions to gut serotonin dynamics are implicated in the altered motility and visceral sensitivity that characterize IBS.

Should I stop using sucralose because of this study? This study is investigational, conducted in mice at doses above human intake levels. There is not enough evidence to recommend stopping sucralose based on this research alone. Watch for follow-up human studies, and raise the question with your doctor if gut symptoms correlate with dietary patterns.

References

1. Akira Aoki, Jonathan P. Jacobs, Yoshinori Okamoto (2026). Sucralose Alters Gut Microbiota, Intestinal Metabolites, and Epithelial Serotonergic Responses to Visceral Stimulation in Mice Exposed to Chronic Restraint Stress. Nutrients. https://doi.org/10.3390/nu18162660
2. Lucía A. Méndez-García, Nallely Bueno-Hernández, Miguel A. Cid-Soto, et al. (2022). Ten-Week Sucralose Consumption Induces Gut Dysbiosis and Altered Glucose and Insulin Levels in Healthy Young Adults. Microorganisms. https://doi.org/10.3390/microorganisms10020434
3. Alex Kidangathazhe, Theresah Amponsah, Abhijit Maji, et al. (2025). Synthetic vs. non-synthetic sweeteners: their differential effects on gut microbiome diversity and function. Frontiers in Microbiology. https://doi.org/10.3389/fmicb.2025.1531131
4. Aranza Mejía-Muñoz, Jessica Cedillo Monter, Héctor Iván Saldívar-Cerón, Galileo Escobedo, Sonia Leon-Cabrera (2026). Sucralose and the Gut–Immune Axis: Emerging Evidence Linking Dysbiosis, Barrier Alterations, and Implications for Colitis and Colorectal Cancer Immunotherapy. Biomedicines. https://doi.org/10.3390/biomedicines14040917